Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
TCMD · Nasdaq · United States · Surgical & Medical Instruments & Apparatus
In shortTACTILE SYSTEMS TECHNOLOGY INC is profitable, generates cash and holds more cash than debt, with revenue growing (+12.5% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 8.9% | 46/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 5.8% | 43/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 8.8% | 44/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 8.1% | 54/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 4.03× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.00× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 28.21× | 100/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 8.52 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 12.3% | 69/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 2.12× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 4.3% | 95/100 |
| Operating margin volatility | 6.1% | 54/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 10.1% | 73/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 208 | 247 | 274 | 293 | 330 |
| Cost of revenue | 60 | 71 | 79 | 76 | 79 |
| Gross profit | 148 | 176 | 195 | 217 | 250 |
| Research & development | 5.7 | 7.1 | 7.8 | 8.8 | 8.5 |
| Operating income | (1.8) | (13) | 18 | 22 | 29 |
| Interest expense | – | 2.8 | 4.1 | 2.1 | 1 |
| Pre-tax income | (2.3) | (15) | 16 | 23 | 31 |
| Income tax | 9.5 | 2.4 | (13) | 6.5 | 12 |
| Net income | (12) | (18) | 29 | 17 | 19 |
| Diluted EPS | −$0.60 | −$0.89 | $1.23 | $0.70 | $0.82 |
| Diluted shares (millions) | 20 | 20 | 23 | 24 | 23 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
8.52 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
8/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 10, 2026